Nhau
Kurapa kweBioOCUS Medical Group Dual CD19/BCMA CAR-T Kunopa Mhedzisiro Inofadza muRefractory Myasthenia Gravis: Rwendo rweMurwere Mudiki
Murwere wekuAustralia Anowana Mhinduro Inoshamisa Yekutanga Nekurapa kweBIOOCUS Medical Group's Dual CD19/CD20 CAR-T yeDLBCL Yakadzoka Muropa
Kukosha Kwekutevera Nguva Dzose Uye Kuongororwa Mushure mekuiswa Kwemasero Eropa
Kuongororwa kwemasero eropa mushure mekuisirwa kwakakosha kune varwere vanoisirwa masero eropa (HSCT). Kuongororwa nguva dzose kunobatsira kuona matambudziko akadai sehutachiona, chirwere chegraft-versus-host (GVHD), uye kudzokera shure, zvichiita kuti pave nekupindira nekukurumidza uye mhedzisiro iri nani.
Kurapa kweCAR-T Kunokunda Kufungidzira Kusina Kunaka muHigh-Grade B-Cell Lymphoma
Ongororo itsva inoratidza kuti kurapwa kweCAR-T kunogona kuvandudza fungidziro yevarwere vane B-cell lymphoma yepamusoro (HGBL), rudzi rweB-cell lymphoma yakakura, kunyangwe mumitsetse yekurapwa inotevera, zvichipa tariro itsva kune varwere ava vane matambudziko.
Kupindira Kwekutanga neCAR-T Therapy yeB-Cell Lymphoma Yakakura Kunoratidza Mhedzisiro Inofadza
Ongororo yakaitwa kare ichienzanisa kurapwa kwekutanga nekwekupedzisira kweCAR-T muvarwere vane B-cell lymphoma yakakura inoratidza kuti kurapwa kwekutanga kunogona kuwedzera mwero wekurarama uye migumisiro mishoma, zvichitsigira kushandiswa kwayo sekurapa kwechipiri.
Kurapa kweCAR-T Kunoratidza Kuchengetedzeka uye Kubudirira Muvarwere Vegomarara Vane Zvirwere Zvinorwisa Muviri Wemuviri Kana Zvirwere Zvinozvirwisa
Chidzidzo chakabudiswa munguva pfupi yapfuura mu Kurapa kweLancet Rheumatology zvinoratidza kuti kurapwa nemasero eCAR-T kwakachengeteka uye kunoshanda pakurapa lymphoma nevarwere vakawanda vemyeloma vanewo zvirwere zve autoimmune kana kuzvimba, zvichipa humbowo hunovimbisa hwekushandiswa kwayo zvakanyanya.
Kunzwisisa Kubudirira Kwemarudzi Emajini eB-ALL Evakuru
Ongororo yakazara mu Ropa inoratidza kufambira mberi kwazvino mukunzwisisa marudzi ejini eB-cell Acute Lymphoblastic Leukemia (B-ALL). Chidzidzo ichi chinoongorora kusiyana kwezvipenyu, zvazvinoreva pakurapa, uye kukosha kwemishonga chaiyo mukuvandudza mhedzisiro yemurwere.
Ongororo Yekubudirira Inosimbisa Kuchengeteka uye Kushanda Kwekurapa kweCD19/CD20 CAR-T paR/R B-NHL
Kuedzwa kwechikamu chekutanga chenzvimbo dzakawanda muChina kwakaratidza kuchengetedzeka uye kushanda zvakanaka kweprizlon-cel, iyo nzira yekurapa ine CD19/CD20 CAR-T ine vanhu vaviri, ichipa tariro itsva kune varwere vane relapse/refractory B-cell non-Hodgkin lymphoma (r/r B-NHL).
Vanyori vatsva veBiomarkers vanofanotaura mhedzisiro yekurapa kweCAR-T mukurapa kweMultiple Myeloma
Chidzidzo chakabudiswa munguva pfupi yapfuura mu Ropa inoziva huwandu hweBCMA (sBCMA) inonyungudika uye huwandu hwekenza yemuviri (MTV) senzira dzinogona kuratidza mhedzisiro yekurapa kweCAR-T muvarwere vane myeloma yakawanda (RRMM) vanodzokera shure uye vasingacharapiki, zvichigadzira nzira dzekurapa dzakagadzirwa nemunhu mumwe nemumwe.
Kurapa kweCAR-T: Ramangwana Rine Tariro Yezvirwere Zvikuru zveT-Cell
Kurapa kweCAR-T, kwakatanga kuri kufambira mberi mukurapa kenza dzeB-cell, kuri kuratidza tarisiro mukurapa kenza dzeT-cell uye kenza yeT-cell acute lymphoblastic leukemia (T-ALL). Kurapa uku kuri kuchinja kunosangana nematambudziko akasiyana asi miedzo yekiriniki yazvino inopa tariro yemhinduro itsva dzekurapa kenza dzeT-cell.
Chidzidzo Chekubudirira Chakabudiswa muRopa: Nanobody-Based CD7 CAR-T Therapy yeAcute Myeloid Leukemia
Chikwata cheLu Daopei Medical Team chabudirira zvikuru mukurapa Acute Myeloid Leukemia (AML) nekudzidza kwavo pakurapa kweCD7 CAR-T kwakavakirwa pa nanobody, kwakaburitswa mumagazini ine mukurumbira. Ropa.
Menin Inhibitors: Mushonga Unoshamisa weAcute Myeloid Leukemia
Kufambira mberi munguva pfupi yapfuura muMenin inhibitors kunopa nzira dzakanaka dzekurapa acute myeloid leukemia (AML), kunanga kushanduka kwemajini uye kupa tariro itsva kune varwere vane matambudziko.